ANI Pharmaceuticals(ANIP.US) Officer Sells US$3.01 Million in Common Stock
Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why
ANI's Generic L-Glutamine Oral Powder Hits Market, Targets $20.1M Annual Sales
Express News | ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
ANI Pharmaceuticals (NASDAQ:ANIP) Shareholder Returns Have Been Decent, Earning 95% in 3 Years
ANI Pharmaceuticals(ANIP.US) Officer Sells US$1.27 Million in Common Stock
Express News | Corrected-ANI Pharmaceuticals - U.S. Annual Sales for Naproxen Tablets About $36.7 Mln, Based on April Mat IQVIA Data (Adds Dropped Words 'based on April Mat IQVIA Data')
Express News | ANI Pharmaceuticals Announces FDA Approval And Launch Of Its Naproxen Delayed-Release Tablets, USP
Express News | ANI Pharmaceuticals Inc - U.S. Annual Sales for Naproxen Tablets Approximately $36.7 Million
Express News | ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, Usp
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
ANI Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
ANI Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $94
Express News | ANI Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $94 From $87
Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals
Truist Financial Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating
Express News | ANI Pharmaceuticals’ CEO Nikhil Lalwani Named Ey Entrepreneur of the Year® 2024 New Jersey Award Winner
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
ANI Pharmaceuticals(ANIP.US) Officer Sells US$1.18 Million in Common Stock